在非标生物体中使用的类杀虫剂:发生,暴露,毒性和人类健康风险
Fang Li1, Weiping Xiong1, Chang Zhang1
1College of Environmental Science and Engineering and Key Laboratory of Environmental Biology and Pollution Control (Ministry of Education), Hunan University, Changsha, 410082, PR China.
Journal of environmental management
|April 25, 2025
概括
尼可类杀虫剂被广泛使用,但对人类健康和生态系统构成风险. 本审查审查了它们在环境中的存在,暴露水平和对非目标生物的毒性影响.
科学领域:
- 农业科学 农业科学
- 环境科学 环境科学
- 毒理学 毒理学 毒理学
背景情况:
- 尼可类药物代表第四代杀虫剂,由于其有效性,在农业中被广泛采用.
- 它们的广泛使用导致在食品和环境样本中进行全球检测,将它们归类为新出现的污染物.
- 有关它们对包括人类在内的非目标生物的影响存在担忧,这需要进一步调查.
研究的目的:
- 批判性地审查环境中新烟类物质的发生和暴露水平.
- 评估与暴露于尼可类药物对人类健康的相关风险.
- 系统地审查neonicotinoids对非标生物的毒性影响.
主要方法:
- 对现有关于新烟类药物的发生,暴露和毒性的研究进行文献综述.
- 对各种终点 (急性毒性,生殖性,神经毒性,免疫毒性,基因毒性) 的毒理学数据的系统评估.
- 讨论潜在的毒性机制和识别知识差距.
主要成果:
- 在全球范围内,在各种环境矩阵和食品中经常检测到新类类.
- 记录了对非目标生物的显著毒性影响,影响了多个生理系统.
- 环境和饮食暴露对人类健康的潜在风险相当大,但需要更专注的研究.
结论:
- 子类药物是新兴的污染物,广泛存在于环境中,对人类健康和生态系统有潜在的风险.
- 需要进一步的研究,以充分阐明毒性机制和对非标生物的长期影响.
- 科学指导对于安全和理性地使用新烟类药物至关重要.
相关概念视频
Types of Toxins
1.4K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
1.4K
Toxic Reactions: Overview
913
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
913
Effects of Chemicals: Overview
1.2K
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
1.2K
Mutagenicity and Carcinogenicity
1.1K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.1K
Drugs Acting on Autonomic Ganglia: Stimulants
1.2K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.2K
Hypothesis: Accept or Fail to Reject?
27.4K
The outcome of any hypothesis testing leads to rejecting or not rejecting the null hypothesis. This decision is taken based on the analysis of the data, an appropriate test statistic, an appropriate confidence level, the critical values, and P-values. However, when the evidence suggests that the null hypothesis cannot be rejected, is it right to say, 'Accept' the null hypothesis?
There are two ways to indicate that the null hypothesis is not rejected. 'Accept' the null...
There are two ways to indicate that the null hypothesis is not rejected. 'Accept' the null...
27.4K


